Protalix BioTherapeutics Inc

News

Investing in Protalix BioTherapeutics Inc (PLX): What You Must Know

Roman Campbell

Protalix BioTherapeutics Inc’s recently made public that its PRESIDENT AND CEO Bashan Dror acquired Company’s shares for reported $0.1 million ...

Analysts Viewpoint

Protalix BioTherapeutics Inc (PLX) rating reiterates by H.C. Wainwright

Samantha Gray

In a filing, Protalix BioTherapeutics Inc revealed its PRESIDENT AND CEO Bashan Dror acquired Company’s shares for reported $0.1 million ...

News

A company insider recently sold 168 shares of Protalix BioTherapeutics Inc [PLX]. Should You also Consider to Sale?

Anna Perez

Protalix BioTherapeutics Inc’s recently made public that its Director Bar-Shalev Amos unloaded Company’s shares for reported $314.0 on Nov 18 ...

Analysts Viewpoint

Director Bar-Shalev Amos sold 168 shares of Protalix BioTherapeutics Inc [PLX]

Jaxson Clark

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.